Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01809704
What this trial is testing

Clinical Validation of New OCT System

Who this might be right for
Subjects Presenting With Normal or With Ocular Pathology
Topcon Medical Systems, Inc. 87
Not applicableStudy completedNCT02796976
What this trial is testing

Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population

Who this might be right for
Cardiovascular DiseaseObesityAtherosclerosis+1 more
University of Basel 158
Not applicableStudy completedNCT00760240
What this trial is testing

Ability of Patients With Low Vision to Properly Instill Eye Drops

Who this might be right for
GlaucomaRetinal Pathology
Mid-Atlantic Glaucoma Experts 200
Not applicableEnded earlyNCT01982383
What this trial is testing

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Who this might be right for
Central Serous Chorioretinopathy
George Washington University 2
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Not applicableWithdrawnNCT02655432
What this trial is testing

Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

Who this might be right for
AmblyopiaMyopiaHyperopia+7 more
Université de Montréal
Not applicableStudy completedNCT03753893
What this trial is testing

Ocular Manifestations in Rheumatic Diseases

Who this might be right for
UveitisConjunctivitisKeratoconjunctivitis Sicca+15 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 5,000
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Large-scale testing (Phase 3)Ended earlyNCT05176717
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 5
Not applicableUnknownNCT02151968
What this trial is testing

Traditional Blind Versus Ultrasound-guided Peribulbar Blockade

Who this might be right for
Retinal and Infra-ocular Pathology
Sunnybrook Health Sciences Centre 80
Not applicableStudy completedNCT04115917
What this trial is testing

Evaluation of Discomfort Associated With Scleral Depression During Retina Examinations

Who this might be right for
Retina--DiseasesRetinal DetachmentRetinal Degeneration
New York City Health and Hospitals Corporation 87
Early research (Phase 1)Study completedNCT03888716
What this trial is testing

A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease

Who this might be right for
Mitochondrial DiseasesMitochondrial Respiratory Chain DeficienciesMELAS Syndrome+1 more
Abliva AB 72
Not applicableWithdrawnNCT06112431
What this trial is testing

Eye Health Intervention Study in Upper Manhattan

Who this might be right for
Glaucoma, SuspectDiabetic RetinopathyCataract+2 more
Columbia University
Early research (Phase 1)Study completedNCT02543229
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Who this might be right for
Eye DiseasesMacular DegenerationRetinal Diseases+2 more
Opthea Limited 51
Large-scale testing (Phase 3)Study completedNCT01135914
What this trial is testing

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 241
Post-approval studies (Phase 4)Study completedNCT03393767
What this trial is testing

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Large-scale testing (Phase 3)Study completedNCT00769015
What this trial is testing

Low Vision Depression Prevention Trial for Age Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationDepression
Thomas Jefferson University 188
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Study completedNCT00733304
What this trial is testing

An Extension to Study MD7108240

Who this might be right for
Macular Degeneration
GlaxoSmithKline 42
Next Page